电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

AKAP8L 抗体 (N-Term)

AKAP8L 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
产品编号 ABIN7094061
发货至: 中国
  • 抗原 See all AKAP8L 抗体
    AKAP8L (A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
    抗原表位
    • 11
    • 8
    • 6
    • 3
    • 2
    • 1
    • 1
    • 1
    N-Term
    适用
    • 38
    • 13
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    宿主
    • 38
    克隆类型
    • 38
    多克隆
    标记
    • 21
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This AKAP8L antibody is un-conjugated
    应用范围
    • 28
    • 18
    • 8
    • 5
    • 4
    • 3
    • 1
    • 1
    Western Blotting (WB)
    特异性
    AKAP8L Antibody detects endogenous levels of total AKAP8L.
    预测反应
    Pig,Bovine,Horse,Sheep,Rabbit,Dog
    免疫原
    A synthesized peptide derived from human AKAP8L, corresponding to a region within N-terminal amino acids.
    亚型
    IgG
    Top Product
    Discover our top product AKAP8L Primary Antibody
  • 应用备注
    WB 1:500-1:2000
    限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
    储存液
    Sodium azide
    注意事项
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C
    储存方法
    Store at -20 °C. Stable for 12 months from date of receipt.
    有效期
    12 months
  • 抗原
    AKAP8L (A Kinase (PRKA) Anchor Protein 8-Like (AKAP8L))
    别名
    AKAP8L (AKAP8L 产品)
    别名
    HA95 antibody, HAP95 antibody, NAKAP antibody, NAKAP95 antibody, Nakap95 antibody, zgc:85966 antibody, AKAP8L antibody, A-kinase anchoring protein 8 like antibody, A kinase (PRKA) anchor protein 8-like antibody, A-kinase anchoring protein 8 like L homeolog antibody, AKAP8L antibody, Akap8l antibody, akap8l antibody, akap8l.L antibody
    基因ID
    26993
    UniProt
    Q9ULX6
    途径
    SARS-CoV-2 Protein Interactome
You are here: